Search research articles
Contact Us
Filters
Showing results (61-70 of 152) with videos related to
Page
of 16
Sort By:
Cancer Chemotherapy and Pharmacology
|
May 11, 2011
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
Syma Iqbal, Cathryn Rankin, Heinz-Josef Lenz, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2024
Pragmaticism in Cancer Clinical Trials
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, et al.
Investigational New Drugs
|
July 13, 2011
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
Anthony B El-Khoueiry, Cathryn J Rankin, Edgar Ben-Josef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2011
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials
Charles D Blanke, Brian M Bot, David M Thomas, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial
Stephen K Williamson, Sheryl A McCoy, David R Gandara, et al.
American Journal of Clinical Oncology
|
September 23, 2009
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach
Charles D Blanke, Kari Chansky, Kathy L Christman, et al.
Journal of Surgical Oncology
|
October 23, 2008
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665
Burton L Eisenberg, Jonathan Harris, Charles D Blanke, et al.
Clinical Colorectal Cancer
|
July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database
Winson Y Cheung, Qian Shi, Michael O'Connell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 7, 2012
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)
Michael B Tomblyn, Bryan H Goldman, Charles R Thomas, et al.
Seminars in Oncology
|
October 5, 2015
The Globalization of Cooperative Groups
Manuel Valdivieso, Benjamin W Corn, Janet E Dancey, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 152) with videos related to
Sort By:
Page
of 16
Cancer Chemotherapy and Pharmacology
|
May 11, 2011
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
Syma Iqbal, Cathryn Rankin, Heinz-Josef Lenz, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2024
Pragmaticism in Cancer Clinical Trials
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, et al.
Investigational New Drugs
|
July 13, 2011
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
Anthony B El-Khoueiry, Cathryn J Rankin, Edgar Ben-Josef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2011
Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials
Charles D Blanke, Brian M Bot, David M Thomas, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial
Stephen K Williamson, Sheryl A McCoy, David R Gandara, et al.
American Journal of Clinical Oncology
|
September 23, 2009
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach
Charles D Blanke, Kari Chansky, Kathy L Christman, et al.
Journal of Surgical Oncology
|
October 23, 2008
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665
Burton L Eisenberg, Jonathan Harris, Charles D Blanke, et al.
Clinical Colorectal Cancer
|
July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database
Winson Y Cheung, Qian Shi, Michael O'Connell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 7, 2012
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)
Michael B Tomblyn, Bryan H Goldman, Charles R Thomas, et al.
Seminars in Oncology
|
October 5, 2015
The Globalization of Cooperative Groups
Manuel Valdivieso, Benjamin W Corn, Janet E Dancey, et al.
Page
of 16